MANAGEMENT TEAM

The NeuroVista management team has a proven track-record of developing and commercializing innovative medical technologies that have a profound impact on healthcare. Unique domain expertise in the design and development of implantable neurological products, combined with a passion to improve the lives of people with debilitating conditions, has compelled this accomplished team to pursue the development of revolutionary technologies for the management and treatment of epilepsy.

W. Douglas Sheffield VMD, PhD
VICE PRESIDENT OF CLINICAL RESEARCH

W. Douglas SheffieldW. Douglas Sheffield VMD, PhD is NeuroVista's Vice President of Clinical Research and brings to the team over 25 years of experience directing the research and development of medical devices, biologics and pharmaceutical products.

Previously, Doug was the Director of New Technologies at Northstar Neuroscience, Inc., a Seattle-based medical device company seeking to improve neurological recovery following stroke through targeted electrical stimulation of the brain. While at Northstar, Doug was responsible for leading the stroke recovery program that developed a cortical stimulation technology to enhance post stroke motor and language recovery. Additionally, Doug was responsible for the design and execution of all preclinical safety studies.

Prior to this, Doug was with Johnson & Johnson where he was Ethicon's Director of Pharmaceutical Research and Development responsible for developing the Regranex and Interceed technologies. Doug also served as Director of Surgical R&D at Ethicon Endo-Surgery, leading the development of numerous minimally invasive procedures.

Doug is an inventor multiple patents relating to medical devices and has authored and co-authored numerous medical publications. Doug received a BS in biology from Johns Hopkins University, a VMD and PhD in pathology from the University of Pennsylvania and completed a residency in Comparative Medicine at Johns Hopkins School of Medicine.

MEET OUR TEAM